Home / RESCUESKIN's Revolutionary Science and Technology
A foundation in research,
for advanced skin science

Scharp Technologies, its research scientists, and extended network of scientists, clinicians, and health professionals, are leaders in science and technology, pioneering a better approach to health and aging.

feature-row__image

Scientific Direction

RESCUE’s team members participate in various fields of study, including biochemistry, anti-aging, and wellness. They also work in a variety of roles as regulatory officials, clinicians, and scientists. The scope of their expertise provides RESCUE with the resources to research and build scientifically and clinically validated products.

A leading scientific mind

RESCUE Skin’s revolutionary technology is the work of David Scharp, MD. His research continues to pioneer our understanding of how cells work to prolong life. Dr. Scharp is the founder of leading companies including Novocell, Cytotherapeutics, Prodolabs and the Scharp-Lacy Research Institute.

Dr. Scharp has contributed to 15 patents, 200+ publications and continuous NIH and JDRF grants. He has conducted independent work with NASA, McDonnell Douglas and Johnson & Johnson.

DR. DAVID SHARP CV
Groundbreaking clinical research

Scharp Labs and RESCUE conduct ongoing research into how to best support cells to further understand how they function at peak performance. That research helps us to offer the best in class clinically tested products to RESCUE customers.

Our work studying the adult human stem cell-derived technology has shown measurable clinical results in supporting natural dermal fibroblast activity and the resulting acceleration of natural cellular turnover.

The diagram at right shows how properly optimized mesenchymal stem cells appear in population in relation to unoptimized mesenchymal stem cells.

Human mesenchymal stem cell activity unoptimized (left) and optimized (right).
Slide to compare